Completed PHASE1 INTERVENTIONAL 1-arm NCT00628940

PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?

Sponsor: Research Foundation Flanders

Conditions High-grade Glioma of the Brain

Interventions PET images with 18F-fluoromethylcholine

Updated 6 times since 2017 Last updated: May 15, 2018 Started: Jan 12, 2010 Primary completion: Mar 14, 2017 Completion: Mar 22, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00628940, this PHASE1 trial focuses on High-grade Glioma of the Brain and remains completed. Sponsored by Research Foundation Flanders, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Feb 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Feb 2019 [monthly]

Completed PHASE1

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Research Foundation Flanders
Special Research Fund, Belgium
University Ghent

Data source: University Ghent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ghent, Belgium